Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-02-07 @ 6:27 AM
Study NCT ID:
NCT01534260
Status:
COMPLETED
Last Update Posted:
2018-08-17
First Post:
2012-02-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype
Sponsor:
Organization: